Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biomedicines ; 11(9)2023 Sep 18.
Article in English | MEDLINE | ID: mdl-37761005

ABSTRACT

Human epidermal growth factor receptor 2 (HER2) is overexpressed in numerous cancer cell types. Therapeutic antibodies and chimeric antigen receptors (CARs) against HER2 were developed to treat human tumors. The major limitation of anti-HER2 CAR-T lymphocyte therapy is attributable to the low HER2 expression in a wide range of normal tissues. Thus, side effects are caused by CAR lymphocyte "on-target off-tumor" reactions. We aimed to develop safer HER2-targeting CAR-based therapy. CAR constructs against HER2 tumor-associated antigen (TAA) for transient expression were delivered into target T and natural killer (NK) cells by an effective and safe non-viral transfection method via nucleofection, excluding the risk of mutations associated with viral transduction. Different in vitro end-point and real-time assays of the CAR lymphocyte antitumor cytotoxicity and in vivo human HER2-positive tumor xenograft mice model proved potent cytotoxic activity of the generated CAR-T-NK cells. Our data suggest transient expression of anti-HER2 CARs in plasmid vectors by human lymphocytes as a safer treatment for HER2-positive human cancers. We also conducted preliminary investigations to elucidate if fucosylated chondroitin sulfate may be used as a possible agent to decrease excessive cytokine production without negative impact on the CAR lymphocyte antitumor effect.

2.
Pharmaceuticals (Basel) ; 14(11)2021 Oct 24.
Article in English | MEDLINE | ID: mdl-34832856

ABSTRACT

The immunosuppression and inhibition of hematopoiesis are considered to be reasons for the development of complications after intensive chemotherapy and allogeneic hematopoietic stem cell transplantation. Chondroitin sulfate (CS), isolated from the fish Salmo salar, and fucosylated chondroitin sulfate (FCS), isolated from the sea cucumber Apostichopus japonicus, were studied for their roles as stimulators of hematopoiesis in a model of cyclophosphamide-induced immunosuppression in mice. The recombinant protein r G-CSF was applied as a reference. The studied polysaccharides were shown to stimulate the release of white and red blood cells, as well as platelets from bone marrow in immunosuppressed mice, while r G-CSF was only responsible for the significant increase in the level of leucocytes. The analysis of different populations of leucocytes in blood indicated that r G-CSF mainly stimulated the production of neutrophils, whereas in the cases of the studied saccharides, increases in the levels of monocytes, lymphocytes and neutrophils were observed. The normalization of the level of the pro-inflammatory cytokine IL-6 in the serum and the recovery of cell populations in the spleen were observed in immunosuppressed mice following treatment with the polysaccharides. An increase in the proliferative activity of hematopoietic cells CD34(+)CD45(+) was observed following ex vivo polysaccharide exposure. Further study on related oligosaccharides regarding their potential as promising drugs in the complex prophylaxis and therapy of hematopoiesis inhibition after intensive chemotherapy and allogeneic hematopoietic stem cell transplantation seems to be warranted.

3.
Mar Drugs ; 16(9)2018 Sep 13.
Article in English | MEDLINE | ID: mdl-30216993

ABSTRACT

Immunosuppression derived after cytostatics application in cancer chemotherapy is considered as an adverse side effect that leads to deterioration of quality of life and risk of infectious diseases. A linear sulfated (1→3)-α-l-fucan M-Fuc prepared by chemical modification of a fucoidan isolated from the brown seaweed Chordaria flagelliformis, along with two structurally related synthetic sulfated oligosaccharides, were studied as stimulators of hematopoiesis on a model of cyclophosphamide immunosuppression in mice. Recombinant granulocyte colony-stimulating factor (r G-CSF), which is currently applied in medicine to treat low blood neutrophils, was used as a reference. Polysaccharide M-Fuc and sulfated difucoside DS did not demonstrate significant effect, while sulfated octasaccharide OS showed higher activity than r G-CSF, causing pronounced neutropoiesis stimulation. In addition, production of erythrocytes and platelets was enhanced after the octasaccharide administration. The assessment of populations of cells in blood and bone marrow of mice revealed the difference in mechanisms of action of OS and r G-CSF.


Subject(s)
Cyclophosphamide/adverse effects , Hematologic Agents/pharmacology , Hematopoiesis/drug effects , Neutropenia/drug therapy , Oligosaccharides/pharmacology , Phaeophyceae/chemistry , Polysaccharides/pharmacology , Animals , Bone Marrow/drug effects , Disease Models, Animal , Filgrastim/pharmacology , Hematologic Agents/chemistry , Hematologic Agents/isolation & purification , Hematopoietic Stem Cells/drug effects , Humans , Immunosuppression Therapy/adverse effects , Male , Mice , Mice, Inbred BALB C , Neutropenia/blood , Neutropenia/chemically induced , Neutrophils/drug effects , Oligosaccharides/chemistry , Oligosaccharides/isolation & purification , Polysaccharides/chemistry , Polysaccharides/isolation & purification , Sulfates/chemistry
4.
Phytomedicine ; 23(2): 166-73, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26926178

ABSTRACT

BACKGROUND: Biopiracy mainly focuses on the use of biological resources and/or knowledge of indigenous tribes or communities without allowing them to share the revenues generated out of economic exploitation or other non-monetary incentives associated with the resource/knowledge. METHODS: Based on collaborations of scientists from five continents, we have created a communication platform to discuss not only scientific topics, but also more general issues with social relevance. This platform was termed 'PhytCancer -Phytotherapy to Fight Cancer' (www.phyt-cancer.uni-mainz.de). As a starting point, we have chosen the topic "biopiracy", since we feel this is of pragmatic significance for scientists working with medicinal plants. RESULTS: It was argued that the patenting of herbs or natural products by pharmaceutical corporations disregarded the ownership of the knowledge possessed by the indigenous communities on how these substances worked. Despite numerous court decisions in U.S.A. and Europe, several international treaties, (e.g. from United Nations, World Health Organization, World Trade Organization, the African Unity and others), sharing of a rational set of benefits amongst producers (mainly pharmaceutical companies) and indigenous communities is yet a distant reality. In this paper, we present an overview of the legal frameworks, discuss some exemplary cases of biopiracy and bioprospecting as excellent forms of utilization of natural resources. CONCLUSIONS: We suggest certain perspectives, by which we as scientists, may contribute towards prevention of biopiracy and also to foster the fair utilization of natural resources. We discuss ways, in which the interests of indigenous people especially from developing countries can be secured.


Subject(s)
Biological Products , Bioprospecting/ethics , Drug Industry/ethics , Ethnopharmacology , Ownership , Plants, Medicinal , Theft , Developing Countries , International Cooperation , Patents as Topic
5.
Mol Med Rep ; 12(3): 4483-4493, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26094694

ABSTRACT

It is known that blood serum proteins of tumor­bearing mice display tumor­specific activity. However, to date, the nature of this activity has remained elusive, and no tumor­specific proteins have been detected in the blood serum of tumor­bearing animals compared with those in healthy animals. The present study postulated and investigated the hypothesis that the observed tumor­specific activity of the blood serum proteins is not associated with the appearance of novel serum proteins but with changes in the conformation of the existing ones. The present study showed conformational changes of two serum albumin proteins and inter­α­trypsin inhibitor heavy chain 4 (ITIH4) in mice with B16 melanoma compared to tumor­free mice, as determined by differences in the products of proteolysis by proteomic analysis following column chromatography. The differences in the conformation of serum albumin in mice with B16 melanoma and tumor­free mice were accompanied by a change in the interaction of these molecules with the fatty acid spin probe 16­doxyl stearic acid. The differential conformation of ITIH4 in mice with B16 melanoma and that in tumor­free mice was accompanied by inhibition of tumor growth and increased life span. Analysis of the role of protease­anti­proteases (serpins) in the serum of tumor­bearing animals in tumor growth confirmed the hypothesis that tumor growth in the body is mediated, at least in part, via balancing of serpins.


Subject(s)
Biomarkers, Tumor/blood , Calcium-Binding Proteins/blood , Glycoproteins/blood , Melanoma, Experimental/blood , Animals , Biomarkers, Tumor/chemistry , Calcium-Binding Proteins/chemistry , Cell Line, Tumor , Glycoproteins/chemistry , Male , Melanoma, Experimental/pathology , Mice, Inbred C57BL , Neoplasm Transplantation , Protein Conformation , Proteinase Inhibitory Proteins, Secretory , Proteolysis , Serum Albumin/chemistry , Serum Albumin/metabolism , Trypsin/chemistry , Tumor Burden
SELECTION OF CITATIONS
SEARCH DETAIL
...